0010 Amino Acids 40 Profile - Plasma

Transcription

1 Accession #: Order #: G Date Collected: Date Received: 01/22/2013 Reference #: Patient: Date of Birth: 02/05/1962 Date of Report: Telephone: Ordering Physician: 1234 Main St. Anywhere, GA Age: Sex: Reprinted: 50 Female 07/10/2013 Fax: Amino Acids 40 - Plasma Interpretation For interpretive information, visit Florida Clinical Lab Lic. # Page 1

2 Accession #: Order #: G Date Collected: Date Received: 01/22/2013 Reference #: Patient: Date of Birth: 02/05/1962 Date of Report: Telephone: Ordering Physician: 1234 Main St. Anywhere, GA Age: Sex: Reprinted: 50 Female 07/10/2013 Fax: Essential Amino Acids Limiting Amino Acids Lysine Methionine Tryptophan 35 L L Branched Chain Amino Acids Isoleucine 29 L L Leucine 76 L L Valine 161 L L Other Essential Amino Acids Phenylalanine 45 L L Histidine Threonine Conditionally Essential Amino Acids Arginine Taurine Glycine Serine Florida Clinical Lab Lic. # Page 2

3 Functional Categories Vitamin B6 Status Markers 14. α-aminoadipic acid < α-amino-n-butyric acid (α-anb) γ-aminobutyric acid (GABA) < Cystathionine < <= 1.5 <= 39 <= 1.5 <= 0.3 Vascular Function 18. Arginine 19. Taurine α-aminoadipic acid <0.5 <= 1.5 Neurotransmitters and Precursors Phenylalanine 45 L L Tyrosine 23. Tryptophan 24. Glutamic Acid 25. Taurine L L Sulfur Amino Acids (Glutathione - related) Methionine Cystathionine <0.2 <= Homocystine <0.6 <= Cystine 30. Taurine Florida Clinical Lab Lic. # Page 3

4 Urea Cycle and Ammonia Detoxification 31. Arginine 32. Citrulline 33. Ornithine 34. Glutamine 35. Asparagine 36. Aspartic Acid Glycine, Serine and Related Amino Acids Alanine Glycine 39. Sarcosine 40. Serine <= Phosphoserine <0.5 <= Ethanolamine 5.4 <= Phosphoethanolamine 3.6 <= 7.4 Collagen - Related Amino Acids 44. Proline 45. Hydroxyproline 46. Lysine <= Hydroxylysine <0.6 <= 0.6 Florida Clinical Lab Lic. # Page 4

5 ß-Amino Acids and Derivatives ß-Alanine 2.7 <= Histidine Carnosine 1.5 <= Methylhistidine 4.6 <= Anserine 30 <= 43 DNA (Thymine) Degradation ß-Aminoisobutyric <0.3 <= 3.2 Muscle-Specific Amino Acids Methylhistidine 36 <= 52 Ratios 55. Phenylalanine/Tyrosine 0.90 <= Glutamic Acid/Glutamine 0.42 H Hydroxyproline/Proline α-anb/leucine Tryptophan/LNAA* *Large neutral amino acids (Leu+Ile+Val+Phe+Tyr) <= <= Florida Clinical Lab Lic. # Page 5

6 The table below shows a customized amino acid formula based on the results of your laboratory profile. The formula is optimized by adding amounts shown in the Grams Added column according to the relative positions of results found. Directions: Adults mix 1 and 1/2 measuring teaspoon (5g) in juice or water 2 times daily between meals as a dietary supplement, or as directed by a health care provider. Children under 12 years old: 3/4 teaspoon, 1-2 times daily between meals. Children under 5 years old: Use 1/4 teaspoon, 1-3 times daily; adjust for body weight. Grams Added % of Formula Active mg/day L-Arginine HCl (80% active) L-Histidine HCl (74% active) L-Isoleucine ,560 L-Leucine ,394 L-Lysine HCl (80% active) L-Methionine L-Phenylalanine ,227 Taurine L-Threonine L-Tryptophan L-Valine ,087 Pyridoxal-5-phosphate Alpha-ketoglutaric acid Total grams added 79 Base Formula amount 221 Total Weight 300 Amino Acid Formula Recommendation L-5-Hydroxytryptophan This formula is intended to optimize essential and conditionallly essential amino acid intake. Other non-essential amino acids can be produced in human tissues. Pyridoxal-5-phosphate (an active form of vitamin B6) and alpha-ketoglutaric acid are key factors needed for the body's utilization of amino acids. The formula may be ordered as a powder that dissolves easily in beverages or may be added to foods such as applesauce. Other forms of supplemental dietary protein or amino acids may need to be restricted while using your customized formula. If enhanced energy levels prevent sleep, avoid bedtime use. This formula is provided as a starting point that may guide decisions about medical treatment based on the test results. It is derived only from the laboratory results included in this report. Final recommendations should be based on consideration of the patient's medical history and current clinical condition. Florida Clinical Lab Lic. # Page 6